Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-22T07:17:50.725Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of Electroconvulsive Therapy on Peripheral Adrenoceptors, Plasma, Noradrenaline, MHPG and Cortisol in Depressed Patients

Published online by Cambridge University Press:  02 January 2018

Eva S. Werstiuk ,
Margaret Coote ,
Lauren Griffith ,
Harry Shannon  and
Meir Steiner
Eva S. Werstiuk
Affiliation:
Department of Biomedical Sciences, McMaster University, Hamilton
Margaret Coote
Affiliation:
Departments of Biomedical Sciences and Psychiatry, McMaster University and St Joseph's Hospital, Hamilton
Lauren Griffith
Affiliation:
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton
Harry Shannon
Affiliation:
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton
Meir Steiner*
Affiliation:
Departments of Psychiatry and Biomedical Sciences, McMaster University, and Department of Psychiatry, St Joseph's Hospital, Hamilton
*
Dr Meir Steiner, Chief and Clinical Director, Department of Psychiatry, St Joseph's Hospital, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada. Fax: (905) 521–6098
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

The mechanism of the antidepressant action of electroconvulsive therapy (ECT) remains unknown. Based on previous work with antidepressant drugs and their effects on the noradrenergic system, we undertook this study to further determine the effects of ECT on selected indices of peripheral adrenoceptor function in depressed patients.

Methods

Binding parameters (Bmax and Kd) of platelet α2- and leukocyte β2-adrenoceptors, plasma noradrenaline (NA), 3-methoxy-4-hydroxy-phenylglycol (MHPG) and cortisol levels were determined in 18 patients, prior to treatment and 14 days after the last of a series of ECTs, and compared with samples obtained from 18 matched control subjects.

Results

Platelet α2-adrenoceptor sites were significantly elevated in untreated patients compared with controls (P < 0.03), but leukocyte β2-adrenoceptor numbers did not differ. Treatment with ECT led to a significant reduction in platelet α2-adrenoceptor numbers, whereas leukocyte β2-adrenoceptor densities increased. Pre-ECT plasma NA, MHPG, and cortisol levels were elevated in patients, compared with controls, and decreased following ECT, but these differences were not statistically significant. Post-ECT plasma NA and β2-adrenoceptor numbers were significantly, negatively correlated (P < 0.05).

Conclusions

These results suggest that platelet α2-adrenoceptors are supersensitive in depressed patients and treatment with ECT results in down-regulation of these receptors, which may be interpreted as a primary therapeutic, ‘normalising’ effect. The post-ECT changes in leukocyte β2-adrenoceptors are probably only secondary to the lower circulating plasma NA levels.

Type
Papers
Information
The British Journal of Psychiatry , Volume 169 , Issue 6 , December 1996 , pp. 758 - 765
Copyright
Copyright © 1996 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1990) The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging. A Task Force Report of the American Psychiatric Association. Washington, DC: APA.Google Scholar
Auffarth, S. E., Steiner, M. & Werstiuk, E. S. (1985) 3H-clonidine binding to membranes of platelets prepared under physiological conditions. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 9, 579–583.CrossRefGoogle ScholarPubMed
Baker, G. B. & Greenshaw, A. J. (1989) Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cellular and Molecular Neurobiology, 9, 1–44.Google Scholar
Brodde, O. E., Engel, G., Hoyer, D., et al (1981) The β-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radio-ligand (±)–125Iodocyanopindolol. Life Sciences, 29, 2189–2198.Google Scholar
Cooper, S. J., Kelly, J. G. & King, D. J. (1985) Adrenergic receptors in depression. Effects of electroconvulsive therapy. British Journal of Psychiatry, 147, 23–29.CrossRefGoogle ScholarPubMed
Daiguji, M., Meltzer, H. Y., Tong, C., et al (1981) α 2-Adrenergic receptors in platelet membranes of depressed patients: No change in number or 3H-yohimbinc affinity. Life Sciences, 29, 2059–2064.Google Scholar
Endicott, J. & Spitzer, R. L. (1979) Use of the research diagnostic criteria and the schedule for affective disorders and schizophrenia to study affective disorders. American Journal of Psychiatry, 136, 52–56.Google ScholarPubMed
Garcia-Sevilla, J. A. (1989) The platelet α 2-adrenoceptor as a potential biological marker in depression. British Journal of Psychiatry, 154 (suppl. 4), 67–72.Google Scholar
Gleiter, C. H. & Nutt, D. J. (1989) Chronic electronconvulsive shock and neurotransmitter receptors – an update. Life Sciences, 44, 985–1006.CrossRefGoogle Scholar
Gupta, R. N., Steiner, M. & Lew, M. (1987) Determination of unconjugated 3-methoxy-4-hydroxyphenylglycol by liquid chromatography for monitoring inhibition of monoamine oxidase activity in plasma. Clinical Chemistry, 33, 2078–2080.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.Google Scholar
Jeanningros, R., Mazzola, P., Azorin, J. M., et al (1991) Beta-adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders. Biological Psychiatry, 29, 789–798.Google Scholar
Kapur, S. & Mann, J. J. (1993) Antidepressant action and the neurobiologic effects of ECT human studies. In The Clinical Science of Electroconvulsive Therapy (ed. Coffey, C. E.), pp. 235–250. Washington: American Psychiatric Press.Google Scholar
Mann, J. J., Mahler, J. C., Wilner, P. J., et al (1990a) Normalization of blunted lymphocyte β-adrenergic responsivity in melancholic inpatients by a course of electroconvulsive therapy. Archives of General Psychiatry, 47, 461–464.CrossRefGoogle ScholarPubMed
Mann, J. J., Manevitz, A. Z., Chen, J. S., et al (1990b) Acute effects of single and repeated electroconvulsive therapy on plasma catecholamines and blood pressure in major depressive disorder. Psychiatry Research, 34, 127–137.Google Scholar
Pandey, G. N., Janicak, P. G., Javaid, J. I., et al (1989) Increased 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disorders. Psychiatry Research, 28, 73–88.Google Scholar
Periyasamy, S. M. & Somani, P. (1985) [3H]Yohimbine binding to human platelet membranes: Evidence for high and low affinity binding sites with negative cooperativity. European Journal of Pharmacology, 116, 17–24.Google Scholar
Piletz, J. E., Halaris, A., Saran, A., et al (1991) Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients. Archives of General Psychiatry, 48, 813–820.Google Scholar
Rudorfer, M. V., Risby, E. D., Osman, O. T., et al (1991) Hypothalamic–pituitary–adrenal axis and monoamine transmitter activity in depression: A pilot study of central and peripheral effects of electroconvulsive therapy. Biological Psychiatry, 29, 253–264.CrossRefGoogle ScholarPubMed
Siever, L. J., Uhde, T. W., Jimerson, D. C., et al (1986) Indices of noradrenergic output in depression. Psychiatry Research, 19, 59–73.Google Scholar
Smith, C. B., Hollingsworth, P. J., Garcia-Sevilla, J. A., et al (1983) Platelet alpha2-adrenoceptors are decreased in number after antidepressant therapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 7, 241–247.Google Scholar
Steiner, M., Brown, G. M. & Goldman, S. (1990) Nocturnal melatonin and cortisol secretion in newly admitted psychiatric inpatients. Implications for affective disorders. European Archives of Psychiatry and Clinical Neuroscience, 240, 21–27.Google Scholar
Weiner, R. D. & Coffey, C. E. (1988) Indications for the use of electroconvulsive therapy. In American Psychiatric Press Review of Psychiatry (eds Frances, A. J. & Hales, R. E.), pp. 458–481. Washington: American Psychiatric Press.Google Scholar
Weizman, A., Gil-Ad, I., Grupper, D., et al (1987) The effect of acute and repeated electroconvulsive treatment on plasma β-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients. Psychopharmacology, 93, 122–126.Google Scholar
Werstiuk, E. S., Steiner, M. & Burns, T. (1990) Studies on leukocyte β-adrenergic receptors in depression, a critical appraisal. Life Sciences, 47, 85–105.Google Scholar
Werstiuk, E. S., Auffarth, S. E. & Steiner, M. (1992) Platelet α 2-adrenergic receptors in depressed patients and healthy volunteers: The effects of desipramine. Pharmacopsychiatry, 25, 199–206.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.